Search clinical trials for: Ixabepilone Lapatinib Capecitabine
Total 3308 results
-
R-PharmGlaxoSmithKlineTerminatedLocally Advanced or Metastatic Breast CancerUnited States, Italy, Australia
-
Tragara Pharmaceuticals, Inc.Terminated
-
Huazhong University of Science and TechnologyUnknown
-
University of California, DavisBristol-Myers Squibb; National Cancer Institute (NCI); Genentech, Inc.TerminatedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
R-PharmNational Cancer Institute (NCI)UnknownBreast CancerUnited States
-
Jiangsu HengRui Medicine Co., Ltd.UnknownHER2 Positive Metastatic Breast CancerChina
-
Memorial Sloan Kettering Cancer CenterGlaxoSmithKlineCompleted
-
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityJiangsu HengRui Medicine Co., Ltd.Recruiting
-
NovartisApproved for marketingNeoplasms, BreastChina, United States, Spain, United Kingdom, Austria, Belgium, Estonia, Canada, Netherlands, Singapore, Australia, Germany, Israel, Italy, Poland, Russian Federation, Sweden, Switzerland, Taiwan, Thailand, Brazil, Denmark, Ireland, Korea... and more
-
GlaxoSmithKlineCompleted
-
Tianjin Hemay Oncology Pharmaceutical Co., LtdRecruiting
-
GlaxoSmithKlineCompleted
-
UNICANCERGlaxoSmithKlineCompletedMetastatic Breast Cancer | 70 Years Old Patients and Over | After One Line of Chemotherapy With TrastuzumabFrance
-
GlaxoSmithKlineCompletedNeoplasms, ColorectalUnited States
-
Cancer Trials IrelandCompletedPancreatic CancerIreland
-
Memorial Sloan Kettering Cancer CenterUniversity of Michigan; Queens Cancer Center of Queens HospitalCompletedMetastatic Breast Cancer | Central Nervous System (CNS) MetastasesUnited States
-
GlaxoSmithKlineCompletedNeoplasms, Gastrointestinal TractTaiwan, Korea, Republic of, United States, Canada, Russian Federation, Mexico
-
National Center for Tumor Diseases, HeidelbergTerminatedGastroEsophageal CancerGermany
-
Hebei Medical UniversityUnknownGastroesophageal Junction AdenocarcinomaChina
-
Abramson Cancer Center of the University of PennsylvaniaCompletedHead and Neck Cancer | Recurrent Metastatic Squamous Neck Cancer With Occult Primary | Recurrent Salivary Gland Cancer | Recurrent Squamous Cell Carcinoma of the Hypopharynx | Recurrent Squamous Cell Carcinoma of the Larynx | Recurrent Squamous Cell Carcinoma of the Lip and Oral Cavity | Recurrent... and other conditionsUnited States
-
Novartis PharmaceuticalsTerminatedNeoplasms, BreastHong Kong, China
-
Puma Biotechnology, Inc.CompletedHER2+ Metastatic Breast Cancer (MBC)United States, Canada, Spain, Singapore, Korea, Republic of, Taiwan, United Kingdom, Israel, Australia, Japan, Hong Kong, Finland, Ireland, Italy, France, Portugal, Germany, Sweden, Belgium, Brazil, Czechia, Switzerland, Argentina, Au... and more
-
Georgetown UniversityGlaxoSmithKlineTerminatedPancreas CancerUnited States
-
Bio-Thera SolutionsUnknownHER2-positive Advanced Breast CancerChina
-
Novartis PharmaceuticalsCompletedMetastases, BrainSpain, Hungary, Poland, Germany, Italy, Russian Federation, Sweden, United Kingdom, Thailand, United States, Belgium, France, Greece, Denmark
-
R-PharmTerminated
-
Tianjin Hemay Pharmaceutical Co., LtdRecruiting
-
UNICANCERCompletedBreast Cancer | Metastatic CancerFrance
-
Xin-Hua XuUnknownHepatocellular CarcinomaChina
-
Latin American Cooperative Oncology GroupGlaxoSmithKlineCompletedBRMS1 | Performance Status Zero to Two for Beginning the Study | Patient With a Maximum of One Chemotherapy | Patient With Progression After TaxanesArgentina, Brazil, Peru
-
Centre Jean PerrinTerminatedColorectal Cancer | Metastatic Breast CancerFrance
-
Yanqiao ZhangUnknownMetastatic Colorectal Cancer
-
Weill Medical College of Cornell UniversityBristol-Myers SquibbCompletedMetastatic Breast CancerUnited States
-
GlaxoSmithKlineTerminatedNeoplasms, BreastUnited States, Spain, Israel, Canada, Germany, Belgium, Austria, Sweden, Greece, France, Italy
-
R-PharmCompletedNeoplasms | Advanced Solid TumorsUnited States
-
University of Wisconsin, MadisonGlaxoSmithKlineCompletedMetastatic Colorectal CancerUnited States
-
GlaxoSmithKlineCompletedMetastatic Breast Cancer | Neoplasms, BreastJapan
-
Sun Yat-sen UniversityRecruitingNasopharyngeal CarcinomaChina
-
R-PharmNational Cancer Institute (NCI); Memorial Sloan Kettering Cancer CenterCompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
National Cancer Institute (NCI)CompletedLymphoma | Small Intestine Cancer | Unspecified Adult Solid Tumor, Protocol SpecificUnited States
-
Accelerated Community Oncology Research NetworkBristol-Myers SquibbCompletedMetastatic Breast CancerUnited States
-
Jiangsu HengRui Medicine Co., Ltd.UnknownHER2 Positive Metastatic Breast CancerChina
-
Mayo ClinicNational Cancer Institute (NCI)CompletedUnspecified Adult Solid Tumor, Protocol SpecificUnited States
-
R-PharmCompleted
-
R-PharmCompletedCancer | Breast CancerTurkey, Chile, Belgium, Portugal, Spain, Italy, United States, Argentina, Austria, Brazil, Canada, France, Germany, Singapore, South Africa, Taiwan, United Kingdom, Israel, Australia, Korea, Republic of, Russian Federation, Ireland, Netherland... and more
-
Sun Yat-sen UniversityCompletedHER2 Positive Breast CancerChina
-
Cedars-Sinai Medical CenterBristol-Myers SquibbTerminatedUrogenital Neoplasms | Adenocarcinoma | Carcinoma | Neoplasms, Glandular and Epithelial | Genital Neoplasms, Male | Prostatic Neoplasms | Prostatic Diseases | Genital Diseases, MaleUnited States
-
Novartis PharmaceuticalsCompletedMetastatic Breast Cancer (MBC) | Locally Advance Breast Cancer (LABC)United Kingdom, Spain
-
Sponsor GmbHGlaxoSmithKline; iOMEDICO AG; Arbeitsgemeinschaft fur Internistische Onkologie; Arbeitskreis Klinische StudienTerminatedMetastatic Breast Cancer | HER2 Positive | First or Second Line Therapy | Failure or Contraindication of Trastuzumab TherapyGermany
-
R-PharmCompletedNovel Epothilone Plus Capecitabine Versus Capecitabine Alone in Patients With Advanced Breast CancerBreast Cancer | MetastasesBelgium, Spain, United States, Argentina, Brazil, Canada, Germany, Peru, Taiwan, United Kingdom, Italy, France, Korea, Republic of, Philippines, Thailand, Mexico, Sweden, China, Hungary, Poland, Greece, Malaysia